Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This clinical trial was evaluated to compare the safety and pharmacokinetics of Besylsartan with Amosartan, which was available commercially after single oral dose in healthy male subjects.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Besylsartan | Experimental | amlodipine besylate 6.944mg+losartan K 100mg |
|
| Amosartan | Active Comparator | amlodipine besylate 7.841mg+losartan K 100mg |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Besylsartan | Drug | Amlodipin besylate 6.944mg+Losartan K 100mg |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in blood concentration of Amlodipine | Detect the change of blood concentration of Amlodipine by LC-MS/MS | 144 hour |
| Change from baseline in blood concentration of Losartan | Detect the change of blood concentration of Losartan by LC-MS/MS | 10 hour |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Amosartan |
| Drug |
Amlodipin besylate 7.841mg+Losartan K 100mg |
|